David O'Dwyer

Credentials: · · · · ·

History

Lung Microbiota Contribute to Pulmonary Inflammation and Disease Progression in Pulmonary Fibrosis
American Journal of Respiratory and Critical Care Medicine · 2019 · First of 18 authors · 297 citations
The Lung Microbiome, Immunity, and the Pathogenesis of Chronic Lung Disease
Review · The Journal of Immunology · 2016 · First of 3 authors · 279 citations
The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis
American Journal of Respiratory and Critical Care Medicine · 2013 · First of 13 authors · 142 citations

Gut Microbiota and Host Regulatory Cross-Talk in Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.9M · University of Michigan at Ann Arbor
2022–2026
Toll-Like Receptors and Respiratory Microbiota Interactions in Idiopathic Pulmonary
National Heart, Lung, and Blood Institute · R00
Contact PI · $747K · University of Michigan at Ann Arbor
2018–2022
Gut Microbiota and Host Regulatory Cross-Talk in Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · R56
Contact PI · $477K · University of Michigan at Ann Arbor
2021–2022
Toll-Like Receptors and Respiratory Microbiota Interactions in Idiopathic Pulmonary Fibrosis
National Heart, Lung, and Blood Institute · K99
Contact PI · $264.6K · University of Michigan at Ann Arbor
2018–2019